Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
<p>Abstract</p> <p>Background</p> <p>Surrogate measures for cardiovascular disease events have the potential to increase greatly the efficiency of clinical trials. A leading candidate for such a surrogate is the progression of intima-media thickness (IMT) of the carotid...
Main Authors: | Morgan Timothy, Terry James G, O'Leary Daniel H, Espeland Mark A, Evans Greg, Mudra Harald |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-03-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://cvm.controlled-trials.com/content/6/1/3 |
Similar Items
-
Blood flow analysis in carotid artery bifurcation by two-dimensional ultrasonic-measurement-integrated simulation
by: Hiroko KADOWAKI, et al.
Published: (2014-09-01) -
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection
by: Vamvakopoulos Joannis E, et al.
Published: (2003-07-01) -
Historical overview of carotid artery surgical treatment
by: Popov Petar, et al.
Published: (2008-01-01) -
Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors
by: Alexandre Wagner Silva de Souza, et al. -
Correlation between significant asymptomatic carotid artery stenosis and severity of peripheral arterial occlusive disease in the lower limb: a retrospective study on 200 patients
by: Zhongjie Pan, et al.
Published: (2019-10-01)